111 studies found for:    "Ocular motility disorders"
Show Display Options
Rank Status Study
1 Completed Evaluation and Treatment of Pediatric Eye Diseases
Condition: Ocular Motility Disorder
Intervention: Procedure: current standard of care treatments
2 Recruiting MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
Conditions: Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
Intervention:
3 Completed Screening for Studies on Nystagmus and Strabismus
Conditions: Nystagmus;   Strabismus
Intervention:
4 Completed Eye Teaming Evaluation Study
Condition: Convergence Insufficiency
Intervention: Device: NPC targets
5 Unknown  Convergence Insufficiency Treatment Trial (CITT)
Conditions: Convergence Insufficiency;   Binocular Vision Disorder
Interventions: Behavioral: Home-based Pencil Push-Up Therapy;   Behavioral: Home-based Pencil Push-ups with Computer Vision Therapy/Orthoptics;   Behavioral: Office-based Vision Therapy/Orthoptics;   Behavioral: Placebo Office-based Vision Therapy/Orthoptics
6 Completed Study of Eyes and Attention Deficit (SEAD)
Conditions: ADHD;   Convergence Insufficiency;   Accommodative Insufficiency
Intervention:
7 Recruiting Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency
Condition: Convergence Insufficiency
Intervention: Procedure: Office-based vergence/accommodative therapy
8 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
9 Recruiting Convergence Insufficiency Treatment Study (CITS)
Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy;   Procedure: Near target push-ups;   Other: Placebo home-based computer vergence/accommodative therapy;   Procedure: Placebo yoked prism flippers
10 Completed Randomized Trial of Treatments for Convergence Insufficiency
Condition: Convergence Insufficiency
Interventions: Procedure: Pencil Push-ups;   Procedure: Office-based Vision Therapy;   Procedure: Placebo Office-based Vision Therapy
11 Completed Effectiveness of Rituximab in Pediatric OMS Patients.
Conditions: Opsoclonus-myoclonus Syndrome;   Opsoclonus;   Myoclonus;   Ataxia
Intervention: Drug: rituximab
12 Recruiting Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
Conditions: Opsoclonus Myoclonus Syndrome;   Neuroblastoma
Interventions: Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
13 Completed Surgery and Convergence Insufficiency Intermittent Exotropia
Condition: Complications
Interventions: Procedure: Post exercise Surgery;   Procedure: Orthoptics;   Procedure: Postop orthoptics;   Procedure: Post exercises surgery
14 Completed A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children
Condition: Convergence Insufficiency
Interventions: Procedure: Base-in prism glasses for reading;   Procedure: Placebo reading glasses
15 Recruiting Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
Condition: Opsoclonus-myoclonus Syndrome
Intervention:
16 Recruiting Study of Non-surgical Treatment Versus Observation in Asian Children With Intermittent Exotropia
Condition: Intermittent Exotropia
Intervention: Procedure: Non surgical therapy
17 Completed Risk Factors for Progressive Supranuclear Palsy (PSP)
Condition: Progressive Supranuclear Palsy
Intervention:
18 Completed Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Condition: Infantile Nystagmus Syndrome
Interventions: Drug: topical brinzolamide 1% in 5mL ophthalmic medication;   Drug: Placebo in 5 mL dispenser
19 Recruiting Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Conditions: Muscular Dystrophy;   Congenital Muscular Dystrophy;   Fukutin-related Protein Gene;   Limb Girdle;   FKRP Gene;   Childhood Onset LGMD;   Adult Onset LGMD;   POMT1;   POMT2;   POMGnT1;   LARGE;   Alpha Dystroglycan;   Dystroglycanopathy;   Centronuclear;   Multiminicore;   Multicore;   Minicore;   Congenital Fiber Type Disproportion;   Myotubular;   Nemaline;   Congenital Myopathy;   Neuromuscular;   Rigid Spine;   Phenotype-Genotype Correlation;   Cough Assisted Device;   Neuromuscular Disease;   Respiratory Exacerbation;   Invasive Ventilation;   Chest Physiotherapy;   Congenital Myopathies;   Genetic Mutations;   Hypertrophic Cardiomyopathy;   Wheelchair Use;   Cataract;   Opthalmoplegia;   Ullrich Congenital Muscular Dystrophy;   Intermediate Collagen VI Myopathy;   Laminin Alpha 2 Related Congenital Muscular Dystrophy;   MDC1A;   Merosin Deficient Congenital Muscular Dystrophy;   Congenital Muscular Dystrophy Undiagnosed;   Congenital Muscular Dystrophy Merosin Positive;   Walker Warburg Syndrome;   Muscle Eye Brain Disease;   Fukuyama;   Integrin Alpha 7 Deficiency;   Integrin Alpha 9 Deficiency;   Laminopathy;   Lamin AC;   SEPN 1 Related Myopathies;   Bethlem Myopathy;   Dystroglycanopathies;   LGMD2K;   LGMD2I;   LGMD2L;   LGMD2N;   Actin Aggregation Myopathy;   Cap Disease;   Central Core Disease;   Centronuclear Myopathy;   Core Rod Myopathy;   Hyaline Body Myopathy;   Multiminicore Myopathy;   Myotubular Myopathy;   Nemaline Myopathy;   Tubular Aggregate Myopathy;   Zebra Body Disease Myopathy;   Congenital Myopathy Other;   Reducing Body Myopathy;   Sarcotubular Myopathy;   Spheroid Body Myopathy
Intervention:
20 Completed Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: GDNF & Synchro Med Infusion System

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years